Efficacy of CMX001 as a Treatment for Rabbitpox Virus in Rabbits
Author Information
Author(s): Amanda D. Rice, Mathew M. Adams, Greg Wallace, Andrews M. Burrage, Scott F. Lindsey, Andrew J. Smith, Daniele Swetnam, Brandi R. Manning, Stacey A. Gray, Bernhard Lampert, Scott Foster, Randall Lanier, Alice Robertson, George Painter, Richard W. Moyer
Primary Institution: University of Florida
Hypothesis
Can CMX001 effectively treat symptomatic rabbitpox virus infection in New Zealand White rabbits?
Conclusion
CMX001 is an effective treatment for symptomatic rabbitpox virus infection in rabbits.
Supporting Evidence
- CMX001 treatment was initiated at the onset of observable lesions.
- All groups receiving CMX001 showed a significant survival benefit compared to vehicle controls.
- Treatment with CMX001 resulted in less weight loss compared to vehicle-treated animals.
- Statistically significant increase in survival rates was observed with CMX001 administration.
Takeaway
CMX001 helps rabbits sick with rabbitpox feel better and survive when they start showing symptoms.
Methodology
Rabbits were infected with rabbitpox virus and treated with CMX001 at the onset of symptoms in a randomized, blinded, placebo-controlled study.
Potential Biases
Potential gender bias as previous studies utilized only female rabbits.
Limitations
The study size was limited, which may affect the statistical significance of the results.
Participant Demographics
New Zealand White rabbits, both male and female.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website